This practice names seven of the compounds this site tracks and five more it does not, across a set of pages that each carry a city in the address. It publishes no company name at all: the identity on offer is the brand in the domain, and the copyright line is a bare year.
What David Borenstein charges
David Borenstein does not publish a price today.
David Borenstein also sells 7 compounds this site boards without publishing a price for them: BPC-157 (board ranks no provider), CJC-1295 (board ranks no provider), GHK-Cu, Ipamorelin (board ranks no provider), PT-141, Semax (board ranks no provider) and Sermorelin.
David Borenstein is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
A brand with no company behind it
The copyright line prints a year and stops, so there is no corporate name to search.
The brand in the address is the whole published identity, which is a narrower answer than most readers expect from a comparison of who charges them.
Several locations are listed across two states, each with its own address on the site.
That gives a reader a set of places without a company, which is the reverse of the more common shape here.
Twelve names, seven of them tracked here
The service page lists twelve compounds in a block, seven of which this comparison follows and five of which it does not.
They are named rather than described, and no page linked from it gives any of them a record of its own.
That makes the list a statement of scope rather than a catalogue a reader can price or compare.
It is recorded as scope, and nothing more is inferred from it.
The price a reader would want, and its absence
Neither the service page nor the terms carries a dollar sign, so there is no published figure of any kind.
There is no certificate to reach here because none is claimed, and the sweep that would have found one came back empty.
Publishing a figure somewhere on its own site is true of one hundred and thirty-seven of the two hundred and ten sellers here, so it separates far fewer of them than a reader expects.
The host itself was checked in the same pass as everything above: 404 at a nonsense path, same effective path, which is what any absence recorded here rests on.
States, pharmacy and labs, counted
One hundred and seventy-six of the two hundred and ten sellers here publish no state list at all, and this is one of them, so eligibility is settled inside an intake rather than before one.
Sixteen of the two hundred and ten sellers here name the facility that fills an order; this is one of the one hundred and ninety-four that do not, so there is no facility a reader can look up.
Four of the two hundred and ten sellers here describe lab work as included in what they charge, and this is not one of them.
It declares seven of the sixteen compounds this site tracks, and thirty-five sellers here declare more, so it is an above-average menu rather than a wide one.
Who it's for
Readers who want a long declared list from a single practice.
Buyers near one of the listed locations.
Shoppers comparing which compounds a practice will name at all.
Anyone who wants to see what a site with no published company looks like.
Who should look elsewhere
Anyone who needs a price.
Readers who want a registered company name.
Buyers who need a state footprint rather than a list of offices.
Shoppers looking for NAD+, glutathione or tesamorelin, none of which is named.
Strengths
Names twelve compounds, seven of them tracked here, on one service page
Describes what it offers without claiming an approval it does not have
Keeps its peptide offer separate from its other lines on the page
Answers the category question in plain language rather than in a disclaimer
Trade-offs
Publishes no company name anywhere — the copyright line carries a year and nothing else
Publishes no figure for any compound on the pages read
Publishes no corporate entity, so there is no company a reader can look up
Publishes no state list and names no dispensing pharmacy
How we verified this
Read every page cited on this row as rendered text in a browser-equivalent fetch, with the response decompressed before any character was counted.
Fired a nonsense-path control at this host in the same run and compared the address requested with the address actually served, so no claim here rests on a status code alone.
Joined every text node before scanning for a dollar sign, so a figure split across nested elements could not read as an absence.
Read the copyright line in full and recorded that it carries a year and no company name.
Screened this seller in the live federal warning-letter record by entity and by brand, with a known-good positive control and a nonsense negative control fired in the same run.
Read the company column of every returned record rather than accepting a full-text match, and attached no letter on a name match.
Swept every attribute on the pages read for a certificate, not only the link targets, because certificates in this market hide in data attributes and lightbox images.
Re-counted the state-list, pharmacy-naming and lab-inclusion claims against the current roster rather than reusing figures from an earlier pass.
A provider to compare David Borenstein against
Auren Rx
Auren Rx names both its prescribing group, Wasef Health, and its dispensing pharmacy, VialsRX in Houston, with street addresses and phone numbers, and lets a subscriber pause an auto-refill plan on NAD+, sermorelin, glutathione or GHK-Cu instead of forcing a full cancellation.